Nano-X Imaging (NASDAQ: NNOX) has entered into a distribution agreement with SOLME RC, S.A., a Costa Rica-based medical equipment distributor, to market and support the Nanox.ARC, a multi-source digital tomosynthesis system designed to expand access to 3D medical imaging. The agreement positions Nanox to penetrate a new market in Latin America, following similar moves in Argentina and Peru earlier this year. This development is significant because it underscores Nanox's strategy to drive the global transition to preventive health care by making advanced imaging more accessible and affordable.
Under the agreement, SOLME will oversee marketing, distribution, installation, training, and ongoing technical support for the Nanox.ARC in Costa Rica. SOLME is a registered supplier to the Caja Costarricense de Seguro Social (CCSS), the country's principal purchaser and provider of hospital services. This relationship could facilitate adoption within the public healthcare system, potentially accelerating the technology's integration into routine care. Commercialization will follow applicable regulatory registration, including an initial six-month proof-of-concept device registration period before full registration. This phased approach allows for clinical validation and adaptation to local needs, which is crucial for gaining trust and demonstrating value in a new market.
The Nanox.ARC is a cost-effective, 3D multi-source digital tomosynthesis imaging system designed for ease of use and scalability. It is part of a broader ecosystem that includes Nanox.AI, a suite of AI-based algorithms that augment the interpretation of routine CT imaging to identify early signs often associated with chronic disease; Nanox.CLOUD, a cloud-based platform for secure data management, storage, and advanced imaging analytics; Nanox.MARKETPLACE and USARAD Holdings, which provide access to remote radiology and cardiology experts and comprehensive teleradiology services; and Nanox Health IT, which combines deep healthcare IT expertise with leading technology partners to deliver RIS, PACS, AI, dictation, and secure infrastructure solutions that streamline workflows and support safer, more efficient care delivery. By integrating these components, Nanox aims to lower barriers to adoption, improve utilization, and advance preventive care worldwide.
For Costa Rica, the introduction of the Nanox.ARC could enhance early detection of diseases, improve clinical efficiency, and broaden access to care, particularly in underserved areas. The CCSS, which serves a large portion of the population, stands to benefit from a more scalable and cost-effective imaging solution. Moreover, this agreement represents a strategic step for Nanox in expanding its footprint in Latin America, a region with growing healthcare demands and increasing adoption of digital health technologies. The company's ability to secure partnerships with established distributors like SOLME is critical for navigating local regulatory landscapes and building trust with healthcare providers. As Nanox continues to execute its vision, this agreement could serve as a blueprint for further expansions into other emerging markets, ultimately contributing to better patient outcomes and more efficient healthcare systems.
To view the full press release, visit https://ibn.fm/C77lJ. The latest news and updates relating to NNOX are available in the company's newsroom at https://ibn.fm/NNOX. For full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published, visit https://IBN.ai/Disclaimer.
